WHO-GMP Certified
International quality standards
Vivifi Life Sciences Pvt Ltd is dedicated to improving the quality of life by reducing the burden of disease through innovative pharmaceutical solutions and WHO-GMP certified manufacturing excellence.
ZANVIA - M 50/500 Tablets
Description
Zanvia M 50/500 Tablet is a fixed-dose combination medicine used to control high blood sugar levels in adults with Type 2 diabetes mellitus.
Effective blood glucose management helps reduce the risk of serious complications such as:
- Kidney damage
- Vision impairment
- Nerve damage
- Cardiovascular events including heart attack and stroke
Zanvia M 50/500 may be prescribed:
- As initial combination therapy
- Alongside other antidiabetic medications
For optimal effectiveness, it should be used together with:
- A balanced diabetic diet
- Regular physical activity
- Weight management as advised by a healthcare professional
The dosage depends on the patient’s condition, blood sugar levels, and concurrent medications.
Taking the tablet with meals helps reduce the likelihood of gastrointestinal discomfort.
How Zanvia M 50/500 Tablet Works
Zanvia M 50/500 combines two antidiabetic agents with complementary mechanisms:
- One component enhances incretin activity, improving insulin release and regulating post-meal glucose levels.
- The other component reduces glucose production in the liver and improves insulin sensitivity.
This dual-action approach supports more stable blood sugar control compared to single-drug therapy.
How to Use Zanvia M 50/500 Tablet
For best results:
- Take the tablet with meals
- Take it at the same time each day
- Follow your prescribed diet and exercise plan
- Do not skip doses
- Do not discontinue without consulting your doctor
Regular and consistent use plays a crucial role in long-term diabetes management.
Possible Side Effects
Like all medications, Zanvia M 50/500 Tablet may cause side effects, although not everyone experiences them.
Common side effects may include:
- Nausea
- Diarrhea
- Stomach discomfort
- Headache
- Low blood sugar (especially when used with other antidiabetic medicines)
Most side effects are mild and temporary. Seek medical advice if symptoms persist or worsen.
Key Features
- Combination therapy for Type 2 diabetes
- Dual mechanism for improved glycemic control
- Helps reduce the risk of diabetes-related complications
- Suitable for long-term metabolic management
- WHO-GMP certified manufacturing
- Quality tested under rigorous protocols
Quality Assurance
Zanvia M 50/500 Tablet is manufactured under strict quality control systems aligned with international pharmaceutical standards.
Vivifi Pharma follows WHO-GMP certified manufacturing practices to ensure product safety, efficacy, and consistency.
Manufacturer
Vivifi Pharma
Delivering pharmaceutical excellence through compliance, quality assurance, and therapeutic reliability.
Disclaimer
This information is intended for educational purposes only and should not be considered medical advice. Always consult a healthcare professional before initiating or modifying any treatment.
FAQ
1. What is Zanvia – M 50/500 Tablet used for?
Zanvia – M 50/500 Tablet is prescribed for adults with Type 2 diabetes mellitus to help control high blood sugar levels. It combines two medicines to provide better glycemic control than single-drug therapy and helps reduce the risk of long-term diabetes-related complications.
2. What are the active ingredients in Zanvia – M 50/500?
This tablet contains Sitagliptin and Metformin. Sitagliptin enhances insulin release and regulates post-meal glucose levels, while Metformin reduces glucose production in the liver and improves insulin sensitivity.
3. Why should Zanvia – M 50/500 be taken with meals?
Taking the tablet with meals helps minimize gastrointestinal side effects such as nausea, diarrhea, and stomach discomfort, which may occur due to the Metformin component.
4. Can Zanvia – M 50/500 cause low blood sugar?
When used alone, the risk of hypoglycemia is generally low. However, the risk may increase if it is combined with insulin or other antidiabetic medications. Regular blood glucose monitoring and medical supervision are recommended.
Quality Assured
Rigorous testing protocols